Info on Abiraterone:
As the results of the early stage trials were published in the Journal of Clinical Oncology, abiraterone instantly gained rave reviews as the miracle drug to treat prostate cancer. The mainstream media immediately pounced on the story during the middle of July 2008, hailing the drug as the most significant development in the field of prostate cancer therapy in 70 years...
Phase I results were announce back around July 2008 approx., so it started before that. But, basically this drug got fast tracked compared to some. Johnson & Johnson is the mfg. owner on this drug, it is alot like Ketoconazole but is said to be 10 times as powerful, but without 10 times the side effects. Keto was approved like in 1981, way back but not as PCa drug, but an anti-fugal type drug, the Canadians (bless the neighbors they are) found out on off lable use, it worked at controlling PCa and thus it evolved into off label use for a different ailment. That is the good side of FDA approval items, once approved you have a chance to try it on other ailments. I think it helped in faster tracking that it was similar to Keto which is still used now for 30 years. It seems it will be another useful tool in fighting PCa and also MDX3100 (MDV3100) super casodex looks promising and might be another one that makes it within 1-2 years.
You can get this drug right now without FDA approval, through Dr. Scholz and Lam in California, they have some kind of arrangement with Johnson & Johnson. You would have to call their office and find out how that works. This was mentioned by Mark Moyad in the Dec. Paact Newsletter and he is the guy who knows about non FDA possibilities with PCa drugs.
Dx-2002 total urinary blockage, bPsa 46.6 12/12 biopsies all loaded 75-95% vol.; Gleasons scores 7,8,9's (2-sets), gland size 35, ct and bone scans look clear- ADT3 5 months prior to radiations neutron/photon 2-machines, cont'd. ADT3, quit after 2 yrs. switched to DES 1-mg, off 1+ yr., controlled well, resumed, used intermittently, resumed useage